Thrivent Financial for Lutherans’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.31M | Sell |
|
|||||
|
2025
Q2 | $3.37M | Buy |
|
|||||
|
2025
Q1 | $302K | Sell |
|
|||||
|
2024
Q4 | $1M | Sell |
|
|||||
|
2024
Q3 | $65.5M | Sell |
|
|||||
|
2024
Q2 | $77.4M | Sell |
|
|||||
|
2024
Q1 | $153M | Buy |
|
|||||
|
2023
Q4 | $105M | Buy |
|
|||||
|
2023
Q3 | $6.69M | Sell |
|
|||||
|
2023
Q2 | $7.18M | Buy |
|
|||||
|
2023
Q1 | $441K | Sell |
|
|||||
|
2022
Q4 | $5.07M | Sell |
|
|||||
|
2022
Q3 | $16.4M | Buy |
|
|||||
|
2022
Q2 | $13.1M | Buy |
|
|||||
|
2022
Q1 | $14.2M | Sell |
|
|||||
|
2021
Q4 | $33.4M | Buy |
|
|||||
|
2021
Q3 | $21.5M | Buy |
|
|||||
|
2021
Q2 | $19.2M | Sell |
|
|||||
|
2021
Q1 | $18.2M | Sell |
|
|||||
|
2020
Q4 | $16.5M | Sell |
|
|||||
|
2020
Q3 | $15M | Sell |
|
|||||
|
2020
Q2 | $12.3M | Sell |
|
|||||
|
2020
Q1 | $11M | Sell |
|
|||||
|
2019
Q4 | $25.5M | Buy |
|
|||||
|
2019
Q3 | $11.9M | Sell |
|
|||||
|
2019
Q2 | $13.3M | Buy |
|
|||||
|
2019
Q1 | $13.5M | Buy |
|
|||||
|
2018
Q4 | $10.5M | Buy |
|
|||||
|
2018
Q3 | $12.4M | Buy |
|
|||||
|
2018
Q2 | $1.23M | Sell |
|
|||||
|
2018
Q1 | $1.18M | Buy |
|
|||||
|
2017
Q4 | $1.13M | Buy |
|
|||||
|
2017
Q3 | $1.1M | Sell |
|
|||||
|
2017
Q2 | $9.78M | Sell |
|
|||||
|
2017
Q1 | $13.4M | Buy |
|
|||||
|
2016
Q4 | $9.44M | Buy |
|
|||||
|
2016
Q3 | $1.29M | Buy |
|
|||||
|
2016
Q2 | $556K | Buy |
|
|||||
|
2016
Q1 | $445K | Buy |
|
|||||
|
2015
Q4 | $432K | Buy |
|
|||||
|
2015
Q3 | $333K | Buy |
|
|||||
|
2015
Q2 | $334K | Sell |
|
|||||
|
2015
Q1 | $2.84M | Buy |
|
|||||
|
2014
Q4 | $2.27M | Sell |
|
|||||
|
2014
Q3 | $2.28M | Hold |
|
|||||
|
2014
Q2 | $2.04M | Buy |
|
|||||
|
2014
Q1 | $2.25M | Buy |
|
|||||
|
2013
Q4 | $1.9M | Sell |
|
|||||
|
2013
Q3 | $1.96M | Buy |
|